More on TFX
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $128.22 |
|
|||
| Open | $130.14 | ||||
| 52 Wk High | $188.79 | ||||
| 52 Wk Low | $125.28 | ||||
| Day High | $131.21 | ||||
| Day Low | $128.69 | ||||
| P/E | 37.70 | ||||
| EPS | $3.46 | ||||
| Volume | 838,283 | ||||
- Teleflex (TFX) PT Lowered to $142 at Truist Securities
- Teleflex completes enrollment in BIOMAG-LL magnesium scaffold study
- Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium Scaffold
- Teleflex study links catheter technology to 70% lower CLABSI risk
- Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology
- Nyxoah Appoints Liam Kelly as Chief Executive Officer
- BofA Securities Upgrades Teleflex (TFX) to Buy
- Form 4 TELEFLEX INC For: Sep 08 Filed by: Salmon Sean
- Form 3 TELEFLEX INC For: Sep 08 Filed by: Salmon Sean
- Form 8-K TELEFLEX INC For: Sep 08
Entities mentioned with TFX
- Earnings | View Related Stories »
- Dividend | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- Show More...
